Comparing the efficacy of prophylactic metoclopramide, ondansetron, and placebo in cesarean section patients given epidural anesthesia

Journal of Clinical Anesthesia

Volumn 13, Issue 6, 2001, Pages 430-435

  Pan, Peter H ^a,b   Moore, Charles H ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Anesthesiology ^*  (United States)

Author keywords

Anesthesia, regional; Antiemetics, cesarean section, obstetrics, 5 HT 3 receptor

Indexed keywords

ADRENALIN; ANTIEMETIC AGENT; CITRATE SODIUM; EPHEDRINE; FENTANYL; LIDOCAINE; METOCLOPRAMIDE; ONDANSETRON; PLACEBO; PROMETHAZINE;

ADULT; ARTICLE; CESAREAN SECTION; CLAMP; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EPIDURAL ANESTHESIA; HEADACHE; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; NAUSEA; PATIENT CARE; PATIENT SATISFACTION; POSTOPERATIVE VOMITING; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SEDATION; TIME; UMBILICAL CORD; VERTIGO; VOMITING;

ADULT; ANESTHESIA, EPIDURAL; ANESTHESIA, OBSTETRICAL; ANTIEMETICS; CESAREAN SECTION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; METOCLOPRAMIDE; ONDANSETRON; POSTOPERATIVE NAUSEA AND VOMITING; PREGNANCY;

EID: 0034802005     PISSN: 09528180     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-8180(01)00294-X     Document Type: Article

References (17)

1. Santos A, Datta S: Prophylactic use of droperidol for control of nausea and vomiting during spinal anesthesia for cesarean section. Anesth Analg 1984;63:85-7.
2. Lussos SA, Bader AM, Thornhill ML, Datta S: The antiemetic efficacy and safety of prophylactic metoclopramide for elective cesarean section delivery during spinal anesthesia. Reg Anesth 1992;17:126-30.
3. Chestnut DH, Vandewalker GE, Owen CL, Bates JN, Choi WW: Administration of metoclopramide for prevention of nausea and vomiting during epidural anesthesia for cesarean section. Anesthesiology 1987;66:563-6.
4. Cohen SE, Woods WA, Wyner J: Antiemetic efficacy of droperidol and metoclopramide. Anesthesiology 1984;60:67-9.
5. Melnick B, Sawyer R, Karambelkar D, Phitayakorn P, Uy NT, Patel R: Delayed side effects of droperidol after ambulatory general anesthesia. Anesth Analg 1989;69:748-51.
6. Madej TH, Simpson KH: Comparison of the use of domperidone, droperidol and metoclopramide in the prevention of nausea and vomiting following major gynaecological surgery in day cases. Br J Anaesth 1986;58:879-83.
7. Harrington RA, Hamilton CW, Brogden RN, et al. Metoclopramide: an updated review of its pharmacological properties and clinical use. Drugs 1983;25:451-94.
8. Vella L, Francis D, Houlton P, Reynolds F. Comparison of the antiemetics metoclopramide and promethazine in labour. Br Med J Clin Res Ed 1985;290:1173-5.
9. Fischler M, Bonnet F, Trang H, et al: The pharmacokinetics of droperidol in anesthetized patients. Anesthesiology 1986;64:486-9.
10. Eisenach JC, Dewan DM: Metoclopramide exaggerates stress-induced tachycardia in pregnant sheep. Anesth Analg 1996;82: 607-11.
11. Polati E, Verlato G, Finco G, et al: Ondansetron versus metoclopramide in the treatment of postoperative nausea and vomiting. Anesth Analg 1997;85:395-9.
12. Rust M: Intravenous administration of ondansetron versus metoclopramide for the prophylaxis of postoperative nausea and vomiting. Anaesthetist 1995;44:288-90.
13. Domino KB, Anderson EA, Polissar NL, Posner KL: Comparative efficacy and safety of ondansetron, droperidol, and metoclopramide for preventing postoperative nausea and vomiting: a meta-analysis. Anesth Analg 1999;88:1370-9.
14. Pan PH, Moore CM: Intraoperative antiemetic efficacy of prophylactic ondansetron versus droperidol for cesarean section patients under epidural anesthesia. Anesth Analg 1996;83:982-6.
15. Macario A, Weinger M, Truong P, Lee M: Which clinical anesthesia outcomes are both common and important to avoid? The perspective of a panel of expert anesthesiologists. Anesth Analg 1999;88:1085-91.
16. Tang J, Wang B, White PF, Watcha MF, Qi J, Wender RH: The effect of timing of ondansetron administration on its efficacy, cost-effectiveness, and cost-benefit as a prophylactic antiemetic in the ambulatory setting. Anesth Analg 1998;86:274-82.
17. Gan TJ, Lubarsky DA, Sloan F, et al: How much are patients willing to pay for a completely effective antiemetic? [Abstract]. Anesthesiology 1998;89:3A:A7.